Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News 60 Degrees Pharmaceuticals Inc SXTP

60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under... see more

Current News (NDAQ:SXTP)

VSee Health and 60 Degrees Pharmaceuticals Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire 23 hours ago

60 Degrees Pharmaceuticals and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Accesswire 11 days ago

60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results

GlobeNewswire November 14, 2024

60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch

GlobeNewswire October 3, 2024

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire September 6, 2024

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules

GlobeNewswire September 4, 2024

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire August 28, 2024

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results

GlobeNewswire August 14, 2024

60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study

GlobeNewswire August 12, 2024

Opinion & Analysis (NDAQ:SXTP)

No current opinion is available.

Bullboard Posts (NDAQ:SXTP)

BUY BUY BUY BUY BUY

About to blow the lid off the top
Nibinator - July 25, 2024

RE:RE:SXTP....early a.m runner up on no News

Dang ....forgot to post the NR....   60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial...
Iseneschal - July 19, 2024

RE:SXTP....early a.m runner up on no News

Excuse me.....there was a NR at 5:30....just as I was posting my last post. Regardless.......fluff news......Ya pays yo money and yo...
Iseneschal - July 19, 2024

SXTP....early a.m runner up on no News

The Market Maker is calling all the Retail Chasers to get on board.....because he has lots of paer to flog to them at inflated prices...
Iseneschal - July 19, 2024

SXTP....Thru RBL....next support at 92 cents

Just in case your wondering
Iseneschal - December 21, 2023

SXTP.....False alarm !

Going no where ....fast
Iseneschal - December 21, 2023